These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 32228581

  • 1. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort.
    Bouquet J, Tabor DE, Silver JS, Nair V, Tovchigrechko A, Griffin MP, Esser MT, Sellman BR, Jin H.
    Respir Res; 2020 Mar 30; 21(1):77. PubMed ID: 32228581
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D, Devos N, Lambert C, Brown JR, Clarke SC, Kim VL, Magid-Slav M, Miller BE, Ostridge KK, Patel R, Sathe G, Simola DF, Staples KJ, Sung R, Tal-Singer R, Tuck AC, Van Horn S, Weynants V, Williams NP, Devaster JM, Wilkinson TMA, AERIS Study Group.
    Thorax; 2018 May 30; 73(5):422-430. PubMed ID: 29386298
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Exacerbation induces a microbiota shift in sputa of COPD patients.
    Jubinville E, Veillette M, Milot J, Maltais F, Comeau AM, Levesque RC, Duchaine C.
    PLoS One; 2018 May 30; 13(3):e0194355. PubMed ID: 29579057
    [Abstract] [Full Text] [Related]

  • 6. Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples.
    Alotaibi NM, Chen V, Hollander Z, Leipsic JA, Hague CJ, Murphy DT, DeMarco ML, FitzGerald JM, McManus BM, Ng RT, Sin DD.
    Int J Chron Obstruct Pulmon Dis; 2019 May 30; 14():311-319. PubMed ID: 30774328
    [Abstract] [Full Text] [Related]

  • 7. Sputum Microbiome Dynamics in Chronic Obstructive Pulmonary Disease Patients during an Exacerbation Event and Post-Stabilization.
    López Caro JC, Santibáñez M, García Rivero JL, Villanueva M, Sainz J, González Astorqui P, Hierro M, Rodríguez Porres M, Paras Bravo P, Mira A, Rodriguez JC, Galiana A, on behalf of the ACINAR-microbiome study group.
    Respiration; 2019 May 30; 98(5):447-454. PubMed ID: 31437842
    [Abstract] [Full Text] [Related]

  • 8. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z, Maschera B, Lea S, Kolsum U, Michalovich D, Van Horn S, Traini C, Brown JR, Hessel EM, Singh D.
    Respir Res; 2019 Jun 06; 20(1):113. PubMed ID: 31170986
    [Abstract] [Full Text] [Related]

  • 9. Lung microbiome dynamics in COPD exacerbations.
    Wang Z, Bafadhel M, Haldar K, Spivak A, Mayhew D, Miller BE, Tal-Singer R, Johnston SL, Ramsheh MY, Barer MR, Brightling CE, Brown JR.
    Eur Respir J; 2016 Apr 06; 47(4):1082-92. PubMed ID: 26917613
    [Abstract] [Full Text] [Related]

  • 10. The roles of bacteria and viruses in COPD-Bronchiectasis association: A prospective cohort study.
    He ZF, Lin SZ, Pan CX, Chen ZM, Cen LJ, Zhang XX, Huang Y, Chen CL, Zha SS, Li HM, Lin ZH, Shi MX, Zhong NS, Guan WJ.
    Respir Med; 2024 Sep 06; 231():107692. PubMed ID: 38852923
    [Abstract] [Full Text] [Related]

  • 11. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
    Sun Z, Zhu QL, Shen Y, Yan T, Zhou X.
    Kaohsiung J Med Sci; 2020 Feb 06; 36(2):107-113. PubMed ID: 31782610
    [Abstract] [Full Text] [Related]

  • 12. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study.
    Perotin JM, Dury S, Renois F, Deslee G, Wolak A, Duval V, De Champs C, Lebargy F, Andreoletti L.
    J Med Virol; 2013 May 06; 85(5):866-73. PubMed ID: 23447038
    [Abstract] [Full Text] [Related]

  • 13. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
    Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV.
    J Clin Microbiol; 2014 Aug 06; 52(8):2813-23. PubMed ID: 24850358
    [Abstract] [Full Text] [Related]

  • 14. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY, Li SW, Chin CY, Hsu CW, Lee CC, Yeh YM, Wu KA.
    J Transl Med; 2021 Mar 23; 19(1):121. PubMed ID: 33757530
    [Abstract] [Full Text] [Related]

  • 15. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
    Pragman AA, Knutson KA, Gould TJ, Isaacson RE, Reilly CS, Wendt CH.
    Respir Res; 2019 Jun 07; 20(1):114. PubMed ID: 31174538
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
    Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WO, Moffatt MF, Johnston SL.
    Am J Respir Crit Care Med; 2013 Nov 15; 188(10):1224-31. PubMed ID: 23992479
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.